A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
Clinical trial NCT05707377 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05707377
- Sponsor
- BeOne Medicines
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2027-10-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.